ACIP, housed within the CDC, held a public meeting on Tuesday to discuss the U.S. distribution recommendations — relying on a framework put together by the National Academies of Sciences, Engineering, and Medicine (NASEM).
In it, the organization suggested that 21 million U.S. health care personnel, including first responders, nurses and doctors, should take priority, in a phase known as 1a.
Although the group recommended that nursing home residents in the U.S. be given the vaccine in phase 1b, along with individuals who have preexisting conditions, ACIP concluded that the 3 million individuals living in these facilities be included in phase 1a. Evidence has shown that this group has a very high risk of severe outcomes, with one study in October finding that — despite making up less than 1 percent of the U.S. population — nursing home residents make up
40 percent of COVID-19 deaths.
During Tuesday’s meeting, CDC experts
confirmed that there will likely be 40 million doses of COVID-19 vaccines available by the end of December, a number sufficient to vaccinate 20 million people.
Following phases 1a and 1b of the rollout will be phase 2, which includes all individuals over 65, teachers, school staff, childcare workers and other frontline workers in high-risk settings such as food supply and transit. Phase 3 will include children, young adults and individuals who work in places deemed “important to the functioning of society” such as colleges, banks and factories. Phase 4 will be the remaining Americans.